High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding.

[1]  T. Barrientos-Gutiérrez,et al.  Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. , 2010, The Cochrane database of systematic reviews.

[2]  L. Rodrigo,et al.  Presence of Bacterial Infection in Bleeding Cirrhotic Patients Is Independently Associated with Early Mortality and Failure to Control Bleeding , 2001, Digestive Diseases and Sciences.

[3]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[4]  R. Franchis.  Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension , 2000 .

[5]  A. Burroughs,et al.  Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices , 2000, Hepatology.

[6]  T. Poynard,et al.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis , 1999, Hepatology.

[7]  A. Burroughs,et al.  Infection and hemostasis in decompensated cirrhosis: A prospective study using thrombelastography , 1999, Hepatology.

[8]  S. Basili,et al.  Endotoxaemia, hyperfibrinolysis, and bleeding in cirrhosis , 1999, The Lancet.

[9]  A. Burroughs,et al.  Bacterial infection in the pathogenesis of variceal bleeding , 1999, The Lancet.

[10]  P. Mongan,et al.  Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization , 1998, Anesthesia and analgesia.

[11]  T. Matsukawa,et al.  [Comparative effect of tranexamic acid on the reduction of bleeding during and after cardiac surgery]. , 1998, Masui. The Japanese journal of anesthesiology.

[12]  C. Sabin,et al.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage , 1998, Hepatology.

[13]  L. Bolondi,et al.  Circadian occurrence of variceal bleeding in patients with liver cirrhosis , 1996, Journal of gastroenterology and hepatology.

[14]  A. Sandler,et al.  Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation , 1996, Anesthesiology.

[15]  R. Franchis.  Developing consensus in portal hypertension , 1996 .

[16]  S. Basili,et al.  Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. , 1995, Gastroenterology.

[17]  D. Valla,et al.  Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. , 1995, Gastroenterology.

[18]  R. Logan,et al.  Prognostic factors in upper gastrointestinal bleeding , 1994, Digestive Diseases and Sciences.

[19]  J. Paramo,et al.  Hemostasis in Advanced Liver Disease , 1993, Seminars in thrombosis and hemostasis.

[20]  S. Basili,et al.  Hyperfibrinolysis Resulting from Clotting Activation in Patients with Different Degrees of Cirrhosis , 1993, Hepatology.

[21]  J. González‐Gallego,et al.  Changes of the fibrinolytic system in liver dysfunction: role of portal hypertension. , 1992, Thrombosis research.

[22]  S. Basili,et al.  Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis , 1992, Hepatology.

[23]  K. Huber,et al.  Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. , 1991, Thrombosis research.

[24]  N. Mcintyre,et al.  Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding rates , 1989, Hepatology.

[25]  D. Henry,et al.  Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. , 1989, BMJ.

[26]  R. Kallen,et al.  Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. , 1987, British medical journal.

[27]  F. T. de Dombal,et al.  Prognostic factors in upper G.I. bleeding. , 1986, Endoscopy.

[28]  O. Garden,et al.  Prediction of outcome following acute variceal haemorrhage , 1985, The British journal of surgery.

[29]  S. Ellis,et al.  Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. , 1983, The New England journal of medicine.

[30]  T. Hugh,et al.  Tranexamic acid and upper gastrointestinal haemorrhage--a double-blind trial. , 1976, Gut.

[31]  R. Chakrabarti,et al.  Tranexamic acid in upper gastrointestinal haemorrhage. , 1973, Lancet.

[32]  M. Serra,et al.  Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.

[33]  P. Arcidiacono,et al.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study , 1988 .

[34]  R. Källen,et al.  Tranexamic acid in gastric and duodenal bleeding. , 1987, Scandinavian journal of gastroenterology. Supplement.

[35]  A. Bloom.  Haemostasis and thrombosis , 1981 .

[36]  A. Ost,et al.  Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study. , 1979, Scandinavian journal of gastroenterology.